Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Emerging engineering strategies in bone organoids: From biomimetic scaffolds to dynamic microenvironmental stimulation

Han J., Gu H., Gu Z.

Narrative Review on Hip, published in Bioact Mater (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Bioact Mater (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42027811
PMCID
PMC13099488
DOI
10.1016/j.bioactmat.2026.04.008

Abstract (original English)

Bone organoids have emerged as transformative models for studying bone development and disease by recapitulating complex cellular ecosystems in vitro . However, unlike soft tissues, the unique mineralized matrix and highly dynamic mechanical environment of bone pose significant challenges to classical self-assembly strategies. Consequently, engineering strategies are not merely auxiliary but essential for constructing functional bone organoids. This review provides a comprehensive overview of advanced engineering strategies designed to overcome these biological hurdles. We critically examine the integration of dynamic mechanical microenvironments and the design of biomimetic topologies for guiding cell fate. Furthermore, we explore the application of bone organoids in disease modeling while addressing inherent limitations. Potential solutions based on the convergence of 3D bioprinting, microfluidic organ-on-a-chip systems, and artificial intelligence are proposed. We anticipate that deep interdisciplinary collaboration will accelerate the transition of bone organoids from theoretical exploration to clinical personalized medicine, bridging the gap between basic research and regenerative therapies.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research